CACaption Management, LLC
Institutional investor · Portfolio as of Q2 2021
Top Holdings1,246 positions
META PLATFORMS INC | 563,500 | $195.9M | 2.6% | — | — | — | Increased — |
LOCKHEED MARTIN CORP | 455,000 | $172.1M | 2.2% | — | — | — | New — |
DARDEN RESTAURANTS INC | 778,500 | $113.7M | 1.5% | — | — | — | New — |
CARVANA CO | 320,000 | $96.6M | 1.3% | — | — | — | New — |
WAYFAIR INC | 293,943 | $92.8M | 1.2% | $151.79 | +103.17% | 6 qtrssince 2020-Q1 | Decreased 0 |
WYNN RESORTS LTD | 715,300 | $87.5M | 1.1% | — | — | — | New — |
INTELLIA THERAPEUTICS INC | 504,100 | $81.6M | 1.1% | — | — | — | Increased — |
INTELLIA THERAPEUTICS INC | 439,000 | $71.1M | 0.9% | — | — | — | Increased — |
DARDEN RESTAURANTS INC | 486,800 | $71.1M | 0.9% | $121.94 | 0.00% | 1 qtr | New 58 |
BIOGEN INC | 189,100 | $65.5M | 0.9% | — | — | — | Decreased — |
ENPHASE ENERGY INC | 354,700 | $65.1M | 0.9% | — | — | — | Increased — |
GMS INC | 1.3M | $64.6M | 0.8% | — | — | — | Increased — |
ADIENT PLC | 1.3M | $59.9M | 0.8% | — | — | — | Decreased — |
LAS VEGAS SANDS CORP | 1.1M | $59.6M | 0.8% | — | — | — | New — |
BIOGEN INC | 171,300 | $59.3M | 0.8% | — | — | — | Increased — |
RIO TINTO PLC | 705,500 | $59.2M | 0.8% | — | — | — | New — |
BIOGEN INC | 169,304 | $58.6M | 0.8% | $316.62 | +9.37% | 2 qtrssince 2021-Q1 | Increased 67 |
UNIVAR SOLUTIONS INC | 2.2M | $54.8M | 0.7% | — | — | — | Increased — |
NIKE INC | 342,500 | $52.9M | 0.7% | — | — | — | New — |
CARVANA CO | 175,000 | $52.8M | 0.7% | — | — | — | Increased — |
Caption Management, LLC manages $7.7B across 1246 positions as of Q2 2021. Top holdings: META calls (2.6%), LMT calls (2.2%), DRI puts (1.5%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.
Active quarter - 240 new positions, 197 exits, 64 increased. Top move: BIIB (INCREASED, conviction 67). Portfolio: $7.7B across 1246 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR